[1] Zhou Y, Li X. Demographic characteristics and illegal drug use patterns among attendees of drug cessation programs in China. Subst Use Misuse, 1999, 34(6): 907-920.  doi: 10.3109/10826089909037248
[2] Noble F, Szücs M, Kieffer B, et al. Overexpression of dynamin is induced by chronic stimulation of mu-but not delta-opioid receptors: relationships with mu-related morphine dependence. Mol Pharmacol, 2000, 58(1): 159-166.  doi: 10.1124/mol.58.1.159
[3] Matthes HW, Maldonado R, Simonin F, et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature, 1996, 383(6603): 819-823.  doi: 10.1038/383819a0
[4] Sante AB, Nobre MJ, Brandão ML. Place aversion induced by blockade of mu or activation of kappa opioid receptors in the dorsal periaqueductal gray matter. Behav Pharmacol, 2000, 11(7-8): 583-589.
[5] Dannals RF, Ravert HT, Frost JJ, et al. Radiosynthesis of an opiate receptor binding radiotracer:[11C]carfentanil. Int J Appl Radiat Isot, 1985, 36(4): 303-306.  doi: 10.1016/0020-708X(85)90089-4
[6] Weerts EM, Wand GS, Kuwabara H, et al. Positron emission tomography imaging of mu-and delta-opioid receptor binding in alcohol-dependent and healthy control subjects. Alcohol Cli Exp Res, 2011, 35(12): 2162-2173.  doi: 10.1111/j.1530-0277.2011.01565.x
[7] Tuominen L, Salo J, Hirvonen J, et al. Temperament trait Harm Avoidance associates with μ-opioid receptor availability in frontal cortex: a PET study using[11C]carfentanil. Neuroimage, 2012, 61(3): 670-676.  doi: 10.1016/j.neuroimage.2012.03.063
[8] Zubieta J, Greenwald MK, Lombardi U, et al. Buprenorphine-induced changes in mu-opioid receptor availability in male heroin-dependent volunteers: a preliminary study. Neuropsychopharmacology, 2000, 23(3): 326-334.
[9] Smith JS, Zubieta JK, Price JC, et al. Quantification of delta-opioid receptors in human brain with N1'-([11C]methyl)naltrindole and positron emission tomography. J Cerebr Blood Flow Metab, 1999, 19(9): 956-966.  doi: 10.1097/00004647-199909000-00003
[10] Frost JJ, Mayberg HS, Sadzot B, et al. Comparison of[11C] diprenorphine and[11C] carfentanil binding to opiate receptors in humans by positron emission tomography. J Cerebr Blood Flow Metab, 1990, 10(4): 484-492.  doi: 10.1038/jcbfm.1990.90
[11] Galynker I, Schlyer DJ, Dewey SL, et al. Opioid receptor imaging and displacement studies with[6-O-[11C]methyl] buprenorphine in baboon brain. Nucl Med Biol, 1996, 23(3): 325-331.
[12] 王荣福, 何晓坤, 张春丽, 等.一种新的阿片受体显像剂125I-7α-O-碘烷-特培洛菲的制备及生物学评价.中华医学杂志, 2004, 84(5): 420-422.  doi: 10.3760/j:issn:0376-2491.2004.05.020
[13] David V, Cazala P. Anatomical and pharmacological specificity of the rewarding effect elicited by microinjections of morphine into the nucleus accumbens of mice. Psychopharmacology(Berl), 2000, 150(1): 24-34.  doi: 10.1007/s002130000425
[14] Schoffelmeer AN, Wardeh G, Vanderschuren LJ. Morphine acutely and persistently attenuates nonvesicular GABA release in rat nucleus accumbens. Synapse, 2001, 42(2): 87-94.
[15] Hnasko TS, Sotak BN, Palmiter RD. Morphine reward in dopamine-deficient mice. Nature, 2005, 438(7069): 854-857.  doi: 10.1038/nature04172
[16] Nanni C, Fanti S, Rubello D. 18F-DOPA PET and PET/CT. J Nucl Med, 2007, 48(10): 1577-1579.  doi: 10.2967/jnumed.107.041947
[17] Dackis CA, Gold MS. New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav Rev, 1985, 9(3): 469-477.
[18] Kiyatkin EA, Rebec GV. Impulse activity of ventral tegmental area neurons during heroin self-administration in rats. Neuroscience, 2001, 102(3): 565-580.  doi: 10.1016/S0306-4522(00)00492-9
[19] Chartoff EH, Mague SD, Barhight MF, et al. Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal. J Neurosci, 2006, 26(24): 6450-6457.  doi: 10.1523/JNEUROSCI.0491-06.2006
[20] Le Foll B, Francès H, Diaz J, et al. Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice. Eur J Neurosci, 2002, 15(12): 2016-2026.  doi: 10.1046/j.1460-9568.2002.02049.x
[21] Li T, Hou Y, Cao W, et al. Role of dopamine D3 receptors in basal nociception regulation and in morphine-induced tolerance and withdrawal. Brain Res, 2012, 1433: 80-84.  doi: 10.1016/j.brainres.2011.11.045
[22] Sershen H, Hashim A, Lajtha A. Differences between nicotine and cocaine-induced conditioned place preferences. Brain Res Bull, 2010, 81(1): 120-124.  doi: 10.1016/j.brainresbull.2009.07.015
[23] Laihinen AO, Rinne JO, Ruottinen HM, et al. PET studies on dopamine D1 receptors in the human brain with carbon-11-SCH 39166 and carbon-11-NNC 756. J Nucl Med, 1994, 35(12): 1916-1920.
[24] Wagner HN Jr, Burns HD, Dannals RF, et al. Imaging dopamine receptors in the human brain by positron tomography. Science, 1983, 221(4617): 1264-1266.  doi: 10.1126/science.6604315
[25] Urban NB, Slifstein M, Thompson JL, et al. Dopamine release in chronic cannabis users: a[11C]raclopride positron emission tomography study. Biol Psychiatry, 2012, 71(8): 677-683.  doi: 10.1016/j.biopsych.2011.12.018
[26] Martinez D, Saccone PA, Liu F, et al. Deficits in dopamine D(2) receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addiction. Biol Psychiatry, 2012, 71(3): 192-198.  doi: 10.1016/j.biopsych.2011.08.024
[27] Searle G, Beaver JD, Comley RA, et al. Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist. Biol Psychiatry, 2010, 68(4): 392-399.  doi: 10.1016/j.biopsych.2010.04.038
[28] Spielewoy C, Gonon F, Roubert C, et al. Increased rewarding properties of morphine in dopamine-transporter knockout mice. Eur J Neurosci, 2000, 12(5): 1827-1837.  doi: 10.1046/j.1460-9568.2000.00063.x
[29] 贾少微, 时杰, 欧阳钢, 等.应用单光子发射计算机体层摄影术研究药物滥用对人脑纹状体多巴胺转运体的损害.中华精神科杂志, 2005, 38(2): 69-72.  doi: 10.3760/j:issn:1006-7884.2005.02.002
[30] Cosgrove KP, Tellez-Jacques K, Pittman B, et al. Dopamine and serotonin transporter availability in chronic heroin users: a[123I] β-CIT SPECT imaging study. Psychiatry Res, 2010, 184(3): 192-195.  doi: 10.1016/j.pscychresns.2010.08.001
[31] Shi J, Zhao LY, Copersino ML, et al. PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users. Eur J Pharmacol, 2008, 579(1-3): 160-166.  doi: 10.1016/j.ejphar.2007.09.042